Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group

Journal of Clinical Oncology

Volumn 22, Issue 3, 2004, Pages 446-453

  Freedland, Stephen J ^a   Aronson, William J ^b   Kane, Christopher J ^b   Presti Jr , Joseph C ^b   Amling, Christopher L ^b   Elashoff, David ^b   Terris, Martha K ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CANCER CENTER; CANCER CONTROL; CANCER GRADING; CONTROLLED STUDY; DATA BASE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TUMOR BIOPSY; BLOOD; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; FACTUAL DATABASE; MIDDLE AGED; MULTICENTER STUDY; NEGRO; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; UNITED STATES;

PROSTATE SPECIFIC ANTIGEN;

AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; COHORT STUDIES; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 1442290398     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.04.181     Document Type: Article

References (41)

1. Hubert HB, Feinleib M, McNamara PM, et al: Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977, 1983
2. Criqui MH, Mebane I, Wallace RB, et al: Multivariate correlates of adult blood pressures in nine North American populations: The Lipid Research Clinics Prevalence Study. Prev Med 11:391-402, 1982
3. Mokdad AH, Ford ES, Bowman BA, et al: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79, 2003
4. Flegal KM, Carroll MD, Ogden CL, et al: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727, 2002
5. Bray GA: The underlying basis for obesity: Relationship to cancer. J Nutr 132:34515-34555, 2002
6. Aziz NM, Hartman T, Barrett M, et al: Weight and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Trial. Proc Am Soc Clin Oncol 19:647a, 2000 (abstr 2550)
7. Schuurman AG, Goldbohm RA, Dorant E, et al: Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151:541-549, 2000
8. Giovannucci E, Rimm EB, Stampfer MJ, et al: Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6:557-563, 1997
9. Andersson SO, Wolk A, Bergstrom R. et al: Body size and prostate cancer: A 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89:385-389, 1997
10. Wolk A, Mantzoros CS, Andersson SO, et al: Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst 90:911-915, 1998
11. Moyad MA: Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective. Urology 59:41-50, 2002
12. Yip I, Heber D, Aronson W: Nutrition and prostate cancer. Urol Clin North Am 26:403-411, 1999
13. Snowdon DA, Phillips RL, Choi W: Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 120:244-250, 1984
14. Oefelein MG, Ricchiuti VS, Conrad PW, et al: Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era. Urology 60:120-124, 2002
15. Rodriguez C, Patel AV, Calle EE, et al: Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10:345-353, 2001
16. Calle EE, Rodriguez C, Walker-Thurmond K, et al: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. JAMA 348:1625-1638, 2003
17. Furuya Y, Akimoto S, Akakura K, et al: Smoking and obesity in relation to the etiology and disease progression of prostate cancer in Japan. Int J Urol 5:134-137, 1998
18. Daniell HW: A better prognosis for obese men with prostate cancer. J Urol 155:220-225, 1996
19. Amling CL, Kane CJ, Riffenburgh RH, et al: Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 58: 723-728, 2001
20. Mydlo JH, Tieng NL, Volpe MA, et al: A pilot study analyzing PSA, serum testosterone, lipid profile, body mass index and race in a small sample of patients with and without carcinoma of the prostate. Prostate Cancer Prostatic Dis 4:101-105, 2001
21. Rohrmann S, Roberts WW, Walsh PC, et al: Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 55:140-146, 2003
22. Freedland SJ, Amling CL, Dorey F, et al: Race as an outcome predictor after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60:670-674, 2002
23. Terris MK: Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: Preliminary report. Urology 54:486-489, 1999
24. Borirakchanyavat S, Bhargava V, Shinohara K, et al: Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy. Urology 50:373-378, 1997
25. Freedland SJ, Jalkut M, Dorey F, et al: Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology 56: 87-91, 2000
26. Borboroglu PG, Comer SW, Riffenburgh RH, et al: Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 163:158-162, 2000
27. Freedland SJ, Presti JC Jr, Amling CL, et al: Time trends in biochemical recurrence after radical prostatectomy: Results of the SEARCH database. Urology 61:736-741, 2003
28. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA Cancer J Clin 52:23-47, 2002
29. Moul JW, Connelly RR, Lubeck DP, et al: Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol 166:1322-1327, 2001
30. Tarman GJ, Kane CJ, Moul JW, et al: Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56:1016-1020, 2000
31. Ogden CL, Flegal KM, Carroll MD, et al: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288:1728-1732, 2002
32. Deckelbaum RJ, Williams CL: Childhood obesity: The health issue. Obes Res 9:239S-243S, 2001 (suppl 4)
33. Han M, Partin AW, Piantadosi S, et al: Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 166:416-419, 2001
34. Hsing AW, Chua S Jr, Gao YT. et al: Prostate cancer risk and serum levels of insulin and leptin: A population-based study. J Natl Cancer Inst 93:783-789, 2001
35. Hsing AW, Gao YT, Chua S Jr, et al: Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95:67-71, 2003
36. Ngo NH, Barnard RJ, Tymchuk CN, et al: Effect of diet and exercise on serum insulin, IGF-1, and IGFBP-1 levels and growth of LNCaP cells in vitro. Cancer Causes Control 13:929-935, 2002
37. Tymchuk CN, Tessler SB, Aronson WJ, et al: Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Nutr Cancer 31:127-131, 1998
38. Tymchuk CN, Barnard RJ, Heber D, et al: Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol 166:1185-1189, 2001
39. Pandalai PK, Pilat MJ, Yamazaki K, et al: The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 16:815-820, 1996
40. Wang Y, Corr JG, Thaler HT, et al: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87:1456-1462, 1995
41. Gupta S, Srivastava M, Ahmad N, et al: Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 91:737-743, 2001